Z-2021-2023 Class III Ongoing

Recalled by Randox Laboratories Ltd. — Crumlin (North), N/A

FDA device recall Z-2021-2023 was initiated by Randox Laboratories Ltd. on May 4, 2023 and is designated Class III. Reason for recall: Delay in reporting results due to Quality Controls running high outside of range. Target value and range for ACTH in Immunoassay Premium Level 3, IA2640, lot 2031EC and Immunoassay Premium Control… The recall status is ongoing. Affected quantity: 1 kit.

Recall details

Product Type
Devices
Report Date
Jul 5, 2023
Initiation Date
May 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 kit

Product description

Immunoassay Premium Level 3-In vitro diagnostic use, as assayed quality control material to monitor the accuracy and reproducibility of analytes. Catalog Number: IA2640

Reason for recall

Delay in reporting results due to Quality Controls running high outside of range. Target value and range for ACTH in Immunoassay Premium Level 3, IA2640, lot 2031EC and Immunoassay Premium Control Tri Level kit batch 583135 lot 2031EC has been reassigned on the Roche Cobas e801 due to High recovery outside range

Distribution pattern

CA, IL, VA, WA, WI including PR

Code information

GTIN:05055273203868 Batch/Lot Number: 2031EC Exp. Date: 28th Nov 23

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2021-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2021-2023. Report a data issue: hello@regdatalab.com.